Skip to Content

Photoelectron Corp PECN

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PECN is trading at a 99% premium.
Price
$0.00
Fair Value
$1.73
Uncertainty
Extreme
1-Star Price
$3.62
5-Star Price
Economic Moat
Dcy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PECN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.02
Market Cap
$10.05
Volume/Avg
150 / 575

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Photoelectron Corp is engaged in the design, development & commercialization of the Photon Radiosurgery System, a proprietary, therapeutic device for the treatment of cancerous tumors through the application of x-ray radiation directly to the tumor site. It is manufacturing miniature x-ray systems for a variety of applications in healthcare and non-healthcare related markets.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
37
Website

Valuation

Metric
PECN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
PECN
Quick Ratio
1.75
Current Ratio
3.44
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
PECN
Return on Assets (Normalized)
−118.59%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−140.97%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
MykkbxrpXmqphw$177.5 Bil
Stryker Corp
SYK
XkpqdkqkptYyxp$129.9 Bil
Boston Scientific Corp
BSX
HhbbzzbXvrhmz$114.0 Bil
Medtronic PLC
MDT
VzpvpslHmfyll$101.9 Bil
Edwards Lifesciences Corp
EW
RtymbqsqLlnkpps$52.1 Bil
DexCom Inc
DXCM
ZgklqphzlKrvnt$44.2 Bil
Koninklijke Philips NV ADR
PHG
SkzrrqzvXdfbzn$24.3 Bil
Zimmer Biomet Holdings Inc
ZBH
ClpyblxfLcmgg$22.7 Bil
Steris PLC
STE
NcfhmhtyKlvpsc$22.2 Bil
Align Technology Inc
ALGN
QfyykrfzhGchctwp$18.9 Bil

Sponsor Center